ArticleAmerican journal of cancer research2021

Cyy260, a novel small molecule inhibitor, suppresses non-small cell lung cancer cell growth via JAK2/STAT3 pathway.

Yan Zhuang et al.PubMed ↗Full text ↗

No numbers read from the abstract.